Report overview
This report contains market size and forecasts of Tumor Necrosis Factor Inhibitors Drug in global, including the following market information:
Global Tumor Necrosis Factor Inhibitors Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Tumor Necrosis Factor Inhibitors Drug Market Sales, 2017-2022, 2023-2028, (K Pcs)
Global top five Tumor Necrosis Factor Inhibitors Drug companies in 2021 (%)
The global Tumor Necrosis Factor Inhibitors Drug market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Cimzia (Certolizumab Pegol) Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Tumor Necrosis Factor Inhibitors Drug include Apogenix, AryoGen Biopharma, Bionovis, CASI Pharmaceuticals, Celltrion, Celgene Corporation, Delenex Therapeutics, Dexa Medica and EPIRUS Biopharmaceuticals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Tumor Necrosis Factor Inhibitors Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Tumor Necrosis Factor Inhibitors Drug Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Tumor Necrosis Factor Inhibitors Drug Market Segment Percentages, by Type, 2021 (%)
Cimzia (Certolizumab Pegol)
Enbrel (Etanercept)
Humira ( Adalimumab)
Otezla (Apremilast)
Remicade (Infliximab)
Simponi (Golimumab)
Global Tumor Necrosis Factor Inhibitors Drug Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Tumor Necrosis Factor Inhibitors Drug Market Segment Percentages, by Application, 2021 (%)
Clinic
Hospital
Others
Global Tumor Necrosis Factor Inhibitors Drug Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Tumor Necrosis Factor Inhibitors Drug Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Tumor Necrosis Factor Inhibitors Drug revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Tumor Necrosis Factor Inhibitors Drug revenues share in global market, 2021 (%)
Key companies Tumor Necrosis Factor Inhibitors Drug sales in global market, 2017-2022 (Estimated), (K Pcs)
Key companies Tumor Necrosis Factor Inhibitors Drug sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Apogenix
AryoGen Biopharma
Bionovis
CASI Pharmaceuticals
Celltrion
Celgene Corporation
Delenex Therapeutics
Dexa Medica
EPIRUS Biopharmaceuticals
Janssen Biotech
GlaxoSmithKline
HanAll Biopharma
Intas Pharmaceuticals
LEO Pharma
LG Life Sciences
MedImmune
Momenta Pharmaceuticals
Novartis
PROBIOMED
Reliance Life Sciences
Sandoz
Samsung Bioepis
Sanofi-Aventis
Shanghai CP Guojian Pharmaceutical
Shanghai Pharmaceuticals
Simcere Pharmaceutical
Toyama Chemical
Tsumura
UCB
Zydus Cadila
